Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Growing prevalence of chronic and infectious diseases
3.2.1.2 Technological advancements in chemiluminescence immunoassay
3.2.1.3 Expanding applications in drug development and clinical research
3.2.2 Industry pitfalls & challenges
3.2.2.1 Stringent regulatory scenario
3.2.2.2 High cost of devices
3.3 Growth potential analysis
3.4 Technological landscape
3.5 Regulatory landscape
3.6 Porter’s analysis
3.7 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company market share analysis
4.3 Competitive positioning matrix
4.4 Strategy outlook matrix
Chapter 5 Market Estimates and Forecast, By Product, 2021 – 2032 ($ Mn)
5.1 Key trends
5.2 Instruments
5.2.1 Automated
5.2.2 Semi-automated
5.3 Consumables
5.4 Reagents
5.4.1 Luminophore markers
5.4.2 Enzymatic markers
5.5 Software & services
Chapter 6 Market Estimates and Forecast, By Technology, 2021 – 2032 ($ Mn)
6.1 Key trends
6.2 Chemiluminescence enzyme technology (CLEIA)
6.3 Electrochemiluminescence immunoassay (ECLI)
6.4 Microparticle chemiluminescence immunoassay
Chapter 7 Market Estimates and Forecast, By Sample Type, 2021 – 2032 ($ Mn)
7.1 Key trends
7.2 Blood
7.3 Urine
7.4 Saliva
7.5 Other sample types
Chapter 8 Market Estimates and Forecast, By Application, 2021 – 2032 ($ Mn)
8.1 Key trends
8.2 Therapeutic drug monitoring
8.3 Oncology
8.4 Cardiology
8.5 Endocrinology
8.6 Infectious diseases
8.7 Autoimmune diseases
8.8 Blood screening
8.9 Toxicology
8.10 Newborn screening
8.11 Metabolic disorder
8.12 Gastroenterology
8.13 Respiratory
8.14 Other applications
Chapter 9 Market Estimates and Forecast, By End-Use, 2021 – 2032 ($ Mn)
9.1 Key trends
9.2 Hospitals
9.3 Clinical laboratories
9.4 Pharmaceutical & biotechnology companies
9.5 Other end-users
Chapter 10 Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)
10.1 Key trends
10.2 North America
10.2.1 U.S.
10.2.2 Canada
10.3 Europe
10.3.1 Germany
10.3.2 UK
10.3.3 France
10.3.4 Spain
10.3.5 Italy
10.3.6 Netherlands
10.3.7 Rest of Europe
10.4 Asia Pacific
10.4.1 China
10.4.2 Japan
10.4.3 India
10.4.4 Australia
10.4.5 South Korea
10.4.6 Rest of Asia Pacific
10.5 Latin America
10.5.1 Brazil
10.5.2 Mexico
10.5.3 Argentina
10.5.4 Rest of Latin America
10.6 Middle East and Africa
10.6.1 South Africa
10.6.2 Saudi Arabia
10.6.3 UAE
10.6.4 Rest of Middle East and Africa
Chapter 11 Company Profiles
11.1 Abbott Laboratories
11.2 Bio-Rad Laboratories, Inc.
11.3 Danaher corporation
11.4 DiaSorin S.p.A
11.5 Eurofins Scientific SE
11.6 F. Hoffmann-La Roche Ltd
11.7 H.U. Group Holdings, Inc.
11.8 Maccura Biotechnology Co., Ltd.
11.9 Revvity, Inc.
11.10 Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
11.11 Shenzhen New Industries Biomedical Engineering Co., Ltd.
11.12 Siemens Healthineers AG
11.13 Thermo Fisher Scientific Inc.
11.14 Tosoh Corporation
11.15 Werfen
